Global Bacillus Coagulans Market Growth 2025-2031
Description
The global Bacillus Coagulans market size is predicted to grow from US$ 193 million in 2025 to US$ 331 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031.
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary.
Market Driver:
The Bacillus Coagulans market is driven by the growing consumer demand for probiotics and functional foods that support digestive health and immunity. Bacillus coagulans, a spore-forming probiotic, is valued for its stability and ability to survive harsh manufacturing and gastrointestinal conditions, making it ideal for food, beverages, and dietary supplements. The increasing prevalence of gastrointestinal disorders and heightened awareness of gut health's role in overall wellness further boost market demand.
Market Challenge:
A major challenge in the Bacillus Coagulans market is the stringent regulatory environment for probiotics, requiring extensive research and compliance with safety and efficacy standards. The high cost of production and limited scalability due to specialized fermentation processes can restrict market expansion. Moreover, competition from other probiotics like Lactobacillus and Bifidobacterium strains adds pressure on manufacturers to differentiate their products.
Industry Trends:
The Bacillus Coagulans industry is witnessing innovation in product formulations, including heat-stable and multi-strain probiotic blends, to enhance versatility and effectiveness. The use of Bacillus coagulans in non-traditional applications, such as cosmetics and animal nutrition, is expanding its market potential. Additionally, advancements in fermentation technologies and collaborations between research institutions and companies are driving cost efficiencies and product quality improvements.
Global key players of Bacillus Coagulans include Kerry, WECARE-PROBIOTICS, Sabinsa, etc. The top three players hold a share about 82%. North America is the largest producer, has a share about 51%, followed by Japan and China, with share 17% and 14%, respectively. The largest market is North America, with a share about 31%, followed by Europe and China, both have a share about 24 percent.
LP Information, Inc. (LPI) ' newest research report, the “Bacillus Coagulans Industry Forecast” looks at past sales and reviews total world Bacillus Coagulans sales in 2024, providing a comprehensive analysis by region and market sector of projected Bacillus Coagulans sales for 2025 through 2031. With Bacillus Coagulans sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacillus Coagulans industry.
This Insight Report provides a comprehensive analysis of the global Bacillus Coagulans landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacillus Coagulans portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacillus Coagulans market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacillus Coagulans and breaks down the forecast by Cellular Activity, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacillus Coagulans.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacillus Coagulans market by product type, application, key manufacturers and key regions and countries.
Segmentation by Cellular Activity:
Below 20 Billion CFU/g
20-100 Billion CFU/g
Above 100 Billion CFU/g
Segmentation by Application:
Food and Beverage
Drugs
Supplement Products
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kerry
Sabinsa
Mitsubishi
Chr. Hansen
Synbiotech Inc.
WECARE-PROBIOTICS
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bacillus Coagulans market?
What factors are driving Bacillus Coagulans market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bacillus Coagulans market opportunities vary by end market size?
How does Bacillus Coagulans break out by Cellular Activity, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary.
Market Driver:
The Bacillus Coagulans market is driven by the growing consumer demand for probiotics and functional foods that support digestive health and immunity. Bacillus coagulans, a spore-forming probiotic, is valued for its stability and ability to survive harsh manufacturing and gastrointestinal conditions, making it ideal for food, beverages, and dietary supplements. The increasing prevalence of gastrointestinal disorders and heightened awareness of gut health's role in overall wellness further boost market demand.
Market Challenge:
A major challenge in the Bacillus Coagulans market is the stringent regulatory environment for probiotics, requiring extensive research and compliance with safety and efficacy standards. The high cost of production and limited scalability due to specialized fermentation processes can restrict market expansion. Moreover, competition from other probiotics like Lactobacillus and Bifidobacterium strains adds pressure on manufacturers to differentiate their products.
Industry Trends:
The Bacillus Coagulans industry is witnessing innovation in product formulations, including heat-stable and multi-strain probiotic blends, to enhance versatility and effectiveness. The use of Bacillus coagulans in non-traditional applications, such as cosmetics and animal nutrition, is expanding its market potential. Additionally, advancements in fermentation technologies and collaborations between research institutions and companies are driving cost efficiencies and product quality improvements.
Global key players of Bacillus Coagulans include Kerry, WECARE-PROBIOTICS, Sabinsa, etc. The top three players hold a share about 82%. North America is the largest producer, has a share about 51%, followed by Japan and China, with share 17% and 14%, respectively. The largest market is North America, with a share about 31%, followed by Europe and China, both have a share about 24 percent.
LP Information, Inc. (LPI) ' newest research report, the “Bacillus Coagulans Industry Forecast” looks at past sales and reviews total world Bacillus Coagulans sales in 2024, providing a comprehensive analysis by region and market sector of projected Bacillus Coagulans sales for 2025 through 2031. With Bacillus Coagulans sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacillus Coagulans industry.
This Insight Report provides a comprehensive analysis of the global Bacillus Coagulans landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacillus Coagulans portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacillus Coagulans market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacillus Coagulans and breaks down the forecast by Cellular Activity, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacillus Coagulans.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacillus Coagulans market by product type, application, key manufacturers and key regions and countries.
Segmentation by Cellular Activity:
Below 20 Billion CFU/g
20-100 Billion CFU/g
Above 100 Billion CFU/g
Segmentation by Application:
Food and Beverage
Drugs
Supplement Products
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kerry
Sabinsa
Mitsubishi
Chr. Hansen
Synbiotech Inc.
WECARE-PROBIOTICS
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bacillus Coagulans market?
What factors are driving Bacillus Coagulans market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bacillus Coagulans market opportunities vary by end market size?
How does Bacillus Coagulans break out by Cellular Activity, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
86 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Bacillus Coagulans by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Bacillus Coagulans by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
